These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 3955309)

  • 1. Investigation into the cardioregulatory properties of the alpha 1-adrenoceptor blocker indoramin.
    Pierce V; Shepperson NB; Todd MH; Waterfall JF
    Br J Pharmacol; 1986 Feb; 87(2):433-41. PubMed ID: 3955309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardioregulatory properties of indoramin in the rat.
    Algate DR; Rashid S; Waterfall JF
    J Pharm Pharmacol; 1981 Apr; 33(4):236-9. PubMed ID: 6115907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of prazosin, indoramin and phentolamine on sympathetic nerve activity.
    Ramage AG
    Eur J Pharmacol; 1984 Nov; 106(3):507-13. PubMed ID: 6097460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a central sympathoinhibitory action of prazosin and indoramin.
    Ramage AG
    Eur J Pharmacol; 1986 Feb; 121(1):83-9. PubMed ID: 3956575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation into mechanism of lack of reflex tachycardia in response to hypotensive action of indoramin in dogs.
    Harron DW; Kerr MJ; Shanks RG
    J Cardiovasc Pharmacol; 1984; 6(4):596-600. PubMed ID: 6206312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the mechanisms of hypotensive action of indoramin.
    Gulati K; Srimal RC; Dhawan BN
    Pol J Pharmacol Pharm; 1978; 30(6):811-8. PubMed ID: 755245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cardiovascular effects of centrally and peripherally administered indoramin in conscious rats.
    Porter JP; Bonham AC; Mangiapane ML; Webb RL; Brody MJ
    Eur J Pharmacol; 1985 Feb; 109(1):9-17. PubMed ID: 3996469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the renal effects of indoramin and prazosin.
    Strandhoy JW
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S151-5. PubMed ID: 2423789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of reflex tachycardia by central administration of the alpha-1 adrenoceptor antagonists urapidil and prazosin in anesthetized dogs.
    Shebuski RJ; Zimmerman BG
    J Pharmacol Exp Ther; 1985 Aug; 234(2):456-62. PubMed ID: 2862276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of prazosin and piperoxan on central cardiovascular actions of St 91 in cats.
    McLennan PL; Bentley GA
    Eur J Pharmacol; 1982 Dec; 86(1):19-26. PubMed ID: 7160431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of the hypotensive action of prazosin.
    Oates HF; Graham RM; Stokes GS
    Arch Int Pharmacodyn Ther; 1977 May; 227(1):41-8. PubMed ID: 901072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigations into the bradycardic action of indoramin.
    Lillie C; Harron DW; Kobinger W
    Arzneimittelforschung; 1985; 35(1A):301-5. PubMed ID: 4039170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular effects of intravenous indoramin hydrochloride in man.
    Coleman AJ; Leary WP; Asmal AC
    J Int Med Res; 1979; 7(6):511-8. PubMed ID: 520654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central sympathetic reactivity inhibited by indoramin.
    Davison M; Koss M
    Eur J Pharmacol; 1980 Nov; 68(2):193-6. PubMed ID: 7202486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of urapidil, prazosin, and clonidine on ligand binding to central nervous system receptors, arterial pressure, and heart rate in experimental animals.
    Kellar KJ; Quest JA; Spera AC; Buller A; Conforti A; Dias Souza J; Gillis RA
    Am J Med; 1984 Oct; 77(4A):87-95. PubMed ID: 6091452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vagally mediated bradycardiac effect of prazosin in anaesthetized rats.
    Paakkari I; Puurunen J
    Eur J Pharmacol; 1984 Oct; 105(3-4):223-8. PubMed ID: 6510469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indoramin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and related vascular, cardiovascular and airway diseases.
    Holmes B; Sorkin EM
    Drugs; 1986 Jun; 31(6):467-99. PubMed ID: 3525084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for central alpha 2-adrenoceptor-mediated hypertension in freely moving, normotensive rats.
    Kawasaki H; Takasaki K
    Arch Int Pharmacodyn Ther; 1987 Oct; 289(2):217-33. PubMed ID: 2892472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypotensive and bradycardiac responses to reflex sympathetic inhibition produced by nitroglycerin in rats with sinoaortic deafferentation.
    Ma S; Long JP
    J Cardiovasc Pharmacol; 1993 Jan; 21(1):136-43. PubMed ID: 7678669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of some alpha-adrenoceptor antagonists on central cardio-decelerator mechanisms in the rabbit.
    Evans MH
    Br J Pharmacol; 1985 Mar; 84(3):645-52. PubMed ID: 2859062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.